Latest Advances in Metabolic Syndrome
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".
Deadline for manuscript submissions: closed (30 January 2025) | Viewed by 3028
Special Issue Editor
Interests: diabetes; nutrition; metabolic diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
I am honoured to extend an invitation to participate in our highly anticipated Special Issue, “Latest Advances in Metabolic Syndrome”. This issue is a significant milestone in our collective efforts to understand and manage metabolic syndrome.
MetS is a cluster of conditions that elevate the likelihood of developing heart disease, stroke, chronic kidney diseases, metabolic dysfunction related to steatotic liver disease (MASLD), and type 2 diabetes. The current advancements in understanding and managing metabolic syndrome are focused on various aspects, including exploring genetic and molecular factors, applying lifestyle interventions, utilizing pharmacological treatments, and developing technological innovations. Important subjects that will be addressed include the following:
Current research is unveiling specific genetic markers and pathways associated with metabolic syndrome, shedding light on crucial findings in genomics, biomarkers, and the microbiome. These breakthroughs in genomics are enhancing our understanding of individual susceptibility and identifying potential targets for therapeutic intervention. Studies on the gut microbiota are revealing its profound impact on metabolic health. The ability to modify the gut microbiome through dietary treatments, probiotics, or prebiotics is proving to be a game-changer in influencing the different aspects of metabolic syndrome.
One of the most promising areas of research is the role of lifestyle interventions in managing metabolic syndrome. Personalized eating regimens based on individual genetic and metabolic profiles and innovative exercise programmes have shown great potential in improving metabolic health.
A novel pharmaceutical intervention is being developed to selectively target the biological mechanisms related to insulin resistance, obesity, and lipid metabolism. A combination of medications that target multiple aspects of metabolic syndrome can enhance treatment efficacy and simultaneously address various components.
Examining the connection between inflammation, atherosclerosis, and metabolism is crucial in understanding metabolic syndrome. This relationship has led to the investigation of treatments and lifestyle modifications aimed at reducing systemic inflammation and atherosclerosis.
These developments underscore the importance of a holistic approach to understanding and managing metabolic syndrome. By integrating scientific research with practical therapies, we are making significant strides in our battle against this complex condition. This comprehensive approach should instil confidence in our ability to effectively address metabolic syndrome.
Dr. Anca Pantea Stoian
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic syndrome
- MASLD
- cardiovascular disease
- obesity
- chronic kidney disease
- metabolic therapy
- prediabetes
- type 2 diabetes
- metabolic inflammation
- atherosclerosis
- biomarkers
- nutritional intervention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
